These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12460039)

  • 1. Clinical correlates and mortality impact of left ventricular hypertrophy among new ESRD patients in the United States.
    Stack AG; Saran R
    Am J Kidney Dis; 2002 Dec; 40(6):1202-10. PubMed ID: 12460039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.
    Wang AY; Wang M; Woo J; Lam CW; Lui SF; Li PK; Sanderson JE
    J Am Soc Nephrol; 2004 Aug; 15(8):2186-94. PubMed ID: 15284304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
    Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants and prognostic importance of cardiomegaly among new ESRD patients in the United States.
    Stack AG; Serna H; Ramsanahie A; Henry C
    Ann Epidemiol; 2004 Oct; 14(9):676-85. PubMed ID: 15380799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular geometry and cardiovascular mortality based on haemodialysis patient autopsy analyses.
    Mimura I; Nishi H; Mise N; Mori M; Sugimoto T
    Nephrology (Carlton); 2010 Aug; 15(5):549-54. PubMed ID: 20649875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of timing of nephrology referral and pre-ESRD care on mortality risk among new ESRD patients in the United States.
    Stack AG
    Am J Kidney Dis; 2003 Feb; 41(2):310-8. PubMed ID: 12552491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients.
    Mallamaci F; Zoccali C; Parlongo S; Tripepi G; Benedetto FA; Cutrupi S; Bonanno G; Fatuzzo P; Rapisarda F; Seminara G; Stancanelli B; Bellanuova I; Cataliotti A; Malatino LS;
    Kidney Int; 2002 Nov; 62(5):1884-90. PubMed ID: 12371993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Left ventricular hypertrophy in predialysis chronic kidney disease: impact of cardiomuscular stress markers].
    Kimura T; Iio K; Obi Y; Hayashi T
    Nihon Jinzo Gakkai Shi; 2007; 49(8):1007-13. PubMed ID: 18186229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple myeloma and light chain-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival.
    Abbott KC; Agodoa LY
    Clin Nephrol; 2001 Sep; 56(3):207-10. PubMed ID: 11597035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients.
    Stack AG; Bloembergen WE
    Am J Kidney Dis; 2001 Nov; 38(5):992-1000. PubMed ID: 11684552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise and limitations in physical activity levels among new dialysis patients in the United States: an epidemiologic study.
    Stack AG; Murthy B
    Ann Epidemiol; 2008 Dec; 18(12):880-8. PubMed ID: 19041586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of cardiovascular death in ESRD.
    Zoccali C; Tripepi G; Mallamaci F
    Semin Nephrol; 2005 Nov; 25(6):358-62. PubMed ID: 16298255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A; Naderi AS
    Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE
    Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher brachial-ankle pulse wave velocity is associated with more advanced carotid atherosclerosis in end-stage renal disease.
    Munakata M; Sakuraba J; Tayama J; Furuta T; Yusa A; Nunokawa T; Yoshinaga K; Toyota T
    Hypertens Res; 2005 Jan; 28(1):9-14. PubMed ID: 15969249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A
    J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factors predicting survival in patients on peritoneal dialysis].
    Leaños-Miranda A
    Rev Invest Clin; 1997; 49(5):355-60. PubMed ID: 9580052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epoetin alfa's effect on left ventricular hypertrophy and subsequent mortality.
    Jones M; Schenkel B; Just J
    Int J Cardiol; 2005 Apr; 100(2):253-65. PubMed ID: 15823633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of left ventricular hypertrophy on early and long-term survival after coronary artery bypass grafting.
    Toumpoulis IK; Chamogeorgakis TP; Angouras DC; Swistel DG; Anagnostopoulos CE; Rokkas CK
    Int J Cardiol; 2009 Jun; 135(1):36-42. PubMed ID: 18579225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM
    J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.